RMD
RMD
NYSE · Health Care

Resmed Inc

S&P 500 Large-Cap Stocks Blue Chip Stocks Healthcare Stocks Best Dividend Stocks
$226.31
-1.88 (-0.82%)
As of Mar 25, 9:35 PM ET ·
Financial Highlights (FY 2026)
Revenue
5.10B
Net Income
1.39B
Gross Margin
59.3%
Profit Margin
27.2%
Rev Growth
+12.9%
D/E Ratio
0.11
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 59.3% 59.3% 29.6% 29.6%
Operating Margin 32.7% 29.5% 7.2% 6.1%
Profit Margin 27.2% 25.9% 6.1% 6.6%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 5.10B 4.52B 19.88B 18.80B
Gross Profit 3.03B 2.68B 5.89B 5.57B
Operating Income 1.67B 1.33B 1.43B 1.14B
Net Income 1.39B 1.11B 1.22B 1.24B
Gross Margin 59.3% 59.3% 29.6% 29.6%
Operating Margin 32.7% 29.5% 7.2% 6.1%
Profit Margin 27.2% 25.9% 6.1% 6.6%
Rev Growth +12.9% +12.9% -5.8% +13.5%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 1.88B 1.88B 17.00B 16.78B
Total Equity 16.78B 16.78B 22.02B 19.96B
D/E Ratio 0.11 0.11 0.77 0.84
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 1.71B 1.44B 1.93B 1.63B
Free Cash Flow — — 977.26M 1.00B